tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Shanghai MicroPort MedBot Schedules Board Meeting to Review Interim Results

Story Highlights
Shanghai MicroPort MedBot Schedules Board Meeting to Review Interim Results

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Shanghai MicroPort MedBot (Group) Co., Ltd. Class H ( (HK:2252) ) has shared an announcement.

Shanghai MicroPort MedBot (Group) Co., Ltd. has announced a board meeting scheduled for August 28, 2025, to review and approve the interim results for the first half of 2025. The meeting will also consider the payment of an interim dividend and address other business matters, which could impact the company’s financial strategies and shareholder returns.

The most recent analyst rating on (HK:2252) stock is a Buy with a HK$9.50 price target. To see the full list of analyst forecasts on Shanghai MicroPort MedBot (Group) Co., Ltd. Class H stock, see the HK:2252 Stock Forecast page.

More about Shanghai MicroPort MedBot (Group) Co., Ltd. Class H

Shanghai MicroPort MedBot (Group) Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, focusing on the medical technology industry. The company, along with its subsidiaries, is involved in the development and production of medical robotics and related technologies.

Average Trading Volume: 7,593,761

Technical Sentiment Signal: Buy

Current Market Cap: HK$23.43B

Find detailed analytics on 2252 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1